Dr. S. S. More, Dr. Pranay Gandhi


Background: Sickle cell disease is highly prevalent in some specific castes in some districts of Central India where the growth of child is often delayed. Few data are available in this context and on the issue using the World Health Organization growth norms. Hence we conducted the present study with the aim of describing the growth of affected children aged less than 5 years.
Methodology: An observational cross-sectional study was conducted from January 2019 to December 2019 for a period of 1 year, at the sickle cell centre in a tertiary care hospital in central India. The sample included 75 children with SCD aged 2 to 5 years old in steady state. Anthropometric measurements and socio-demographic data were collected and analyzed. All statistical tests were two-tailed with p<0.05 considered significant.
Results: Median age of study population was 3.57 years. Low weight, height and weight for height Z-scores (<-2SD) were observed. Regression analysis indicated an association of low height-for-age and of low Body Mass Index (BMI)-for-age with age.
Conclusion: This study demonstrates unexpectedly lower mean Z-score for weight, height and weight for height than reported while using WHO norms.


Sickle cell disease, growth

Full Text:



World Health Organization . Management of Haemoglobin Disorders-Report of Joint WHO-TIF Meeting. Accessed on 26th June 2018.

Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.

Lehmann H, Cutbush M. Sickle-cell trait in Southern India. Br Med J. 1952;i:404–5.

Colah R, Mukherjee M, Ghosh K. Sickle cell disease in India. Curr Opin Hematol. 2014;21:215–23.

Rao VR. Genetics and epidemiology of sickle cell anemia in India. ICMR Bull. 1988;9:87–90

Barden EM, Kawchak DA, Ohene-Frempong K, Stallings VA, Zemel BS. Body composition in children with sickle cell disease. Am J Clin Nutr. 2002 Jul;76(1):218–25.

Hauschild M, Theintz G. Severe chronic anemia and endocrine disorders in children. Rev Med Suisse. 2007;3(107):988–991.

Animasahun BA, Temiye EO, Ogunkunle OO, Izuora AN, Njokanma OF. The influence of socioeconomic status on the hemoglobin level and anthropometry of sickle cell anemia patients in steady state at the Lagos University Teaching Hospital. Niger J Clin Pract. 2011;14(4):422–427.

Al-Saqladi AW, Cipolotti R, Fijnvandraat K, Brabin BJ. Growth and nutritional status of children with homozygous sickle cell disease. Ann Trop Paediatr. 2008 Sep;28(3):165–89.

Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, Pegelow CH, Vichinsky E. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood. 1995 Jul 15;86(2):776–83.

Silva CM, Viana MB. Growth deficits in children with sickle cell disease. AArch Med Res. 2002 May-Jun;33(3):308–12.

Al-Saqladi AW, Bi-Gadeen HA, Brabin BJ. Growth in children and adolescents with sickle cell disease in Yemen. Ann Trop Paediatr. 2010;30(4):287–298.

Telfer P, Coen P, Chakravorty S, Wilkey O, Evans J, Newell H, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007;92(7):905–912.

Chawla A, Sprinz PG, Welch J, Heeney M, Usmani N, Pashankar F, et al. Weight status of children with sickle cell disease. Pediatrics. 2013;131(4):e1168–1173.

Stuart MJ, Ronald LN. Sickle-cell disease. Lancet. 2004 Oct 9-15;364(9442):1343–60.

World Health Organisation . Child growth standards-WHO Anthro Survey Analyser and other tools. Accessed on 26th July 2018.

De Onis M, Garza C, Onyango AW Borghi E. Comparison of the WHO child growth standards and the CDC 2000 growth charts. J Nutr. 2007 Jan;137(1):144–8.

De Onis M, Garza C, Onyango AW. Rolland Cachera MF and Nutrition committee of French Pediatric Society WHO growth standards for infants and young children. Arch Pediatr. 2009;16(1):47–53.

National Institute of Statistics . Demographic health survey and multiple indicators and cluster survey of Cameroon 2011. Accessed on 13th July 2013.

Patey RA, Sylvester KP, Rafferty GF, Dick M, Greenough A. The importance of using ethnically appropriate reference ranges for growth assessment in sickle cell disease. Arch Dis Child. 2002 Oct;87(4):352–3.

Habara A, Steinberg MH. Minireview, genetic basis of heterogeneity and severity in sickle cell disease. Exp Biol Med (Maywood) 2016;241(7):689–696.

Gonçalves MS, Bomfim GC, Maciel E, Cergueira I, Lyra I, Zanette A, et al. ßS-Haplotypes in sickle cell anemia patients from Salvador, Bahia, Northeastern Brazil. Braz J Med Biol Res. 2003;36(10):1283–1288.


  • There are currently no refbacks.